Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human 5HT2A Receptor ELISA Kit (AC3027)
Cat.#: ASET-1616
Specifications
Description Human 5HT2A Receptor ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human 5HT2A Receptor concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.019 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.4-6.4 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1253 Human Hes1 ELISA Kit (AC2664) Quantitative inquiry ASET-2146 Human PTF1A ELISA Kit (AC3557) Quantitative inquiry ASET-1970 Human OPA1 ELISA Kit (AC3381) Quantitative inquiry ASET-1441 Human Dysbindin ELISA Kit (AC2852) Quantitative inquiry ASET-2316 Rat IL-6 ELISA Kit (AC3727) Quantitative inquiry ASET-1777 Human Drebrin ELISA Kit (AC3188) Quantitative inquiry ASET-1540 Human Thyroid Hormone Receptor alpha ELISA Kit (AC2951) Quantitative inquiry ASET-1812 Human Dynamin 2 ELISA Kit (AC3223) Quantitative inquiry ASET-2354 Human Renalase ELISA Kit (AC3765) Quantitative inquiry ASET-1475 Human GABARAP ELISA Kit (AC2886) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket